Cargando…

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis

We conducted a meta-analysis to analyse the effect of metformin on survival of pancreatic cancer patients at various stages. We performed a systematic search of PubMed, Embase, Cochrane, and Web of Science to identify all relevant studies. Summary hazard ratios (HR) of survival and 95% confidence in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaogang, Li, Tong, Liu, Zhiqiang, Gou, Shanmiao, Wang, Chunyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517652/ https://www.ncbi.nlm.nih.gov/pubmed/28724893 http://dx.doi.org/10.1038/s41598-017-06207-x

Ejemplares similares

Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis
por: Li, Xiaogang, et al.
Publicado: (2018)

Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
por: Gou, Shanmiao, et al.
Publicado: (2013)

Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials
por: Gou, Shanmiao, et al.
Publicado: (2014)

Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro
por: Yin, Tao, et al.
Publicado: (2014)

MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3
por: Wang, Chunyou, et al.
Publicado: (2016)

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
por: Zhou, Wei, et al.
Publicado: (2015)

Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
por: Shi, Pengfei, et al.
Publicado: (2014)

Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway
por: Liu, Zhiqiang, et al.
Publicado: (2020)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Prediction of Severe Acute Pancreatitis Using a Decision Tree Model Based on the Revised Atlanta Classification of Acute Pancreatitis
por: Yang, Zhiyong, et al.
Publicado: (2015)

Active drain system with reticulated open-pore foam-surface dressing for postoperative pancreatic fistula in a rat model
por: Li, Yang, et al.
Publicado: (2021)

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133(+) Cell Populations and Suppressing ERK/P70S6K Signaling
por: Chai, Xinqun, et al.
Publicado: (2015)

The Reduction of Peripheral Blood CD4(+) T Cell Indicates Persistent Organ Failure in Acute Pancreatitis
por: Yang, Zhiyong, et al.
Publicado: (2015)

A Population-Based Study of the Incidence and Survival of Anorectal Gastrointestinal Stromal Tumor
por: Liu, Zhiqiang, et al.
Publicado: (2019)

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017)

Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to Gemcitabine
por: Yin, Tao, et al.
Publicado: (2011)

High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway
por: Shang, Dan, et al.
Publicado: (2016)

Inverted U-Shaped Relationship between Central Venous Pressure and Intra-Abdominal Pressure in the Early Phase of Severe Acute Pancreatitis: A Retrospective Study
por: Yang, Chong, et al.
Publicado: (2015)

Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020)

Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
por: Shi, Yu-Qi, et al.
Publicado: (2020)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
por: Li, Yang, et al.
Publicado: (2017)

Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017)

Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis
por: Liu, Zhiqiang, et al.
Publicado: (2019)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

The Clinical Effect of Metformin on the Survival of Lung Cancer Patients with Diabetes: A Comprehensive Systematic Review and Meta-analysis of Retrospective Studies
por: Cao, Xun, et al.
Publicado: (2017)

No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
por: Toomey, Paul, et al.
Publicado: (2017)

Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
por: Tang, Yun-Liang, et al.
Publicado: (2017)

The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose
por: Li, Xiang, et al.
Publicado: (2018)

The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017)

Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis
por: Ma, Shu-Juan, et al.
Publicado: (2016)

Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Li, Yin, et al.
Publicado: (2021)

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
por: Choi, Younak, et al.
Publicado: (2016)

Magic of a Common Sugar Pill in Cancer: Can Metformin Raise Survival in Pancreatic Cancer Patients?
por: Gyawali, Mallika, et al.
Publicado: (2021)

Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression
por: Guo, Yao, et al.
Publicado: (2022)

The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis
por: Yao, Xiangyang, et al.
Publicado: (2021)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma: erratum
Publicado: (2017)

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
por: Vernieri, Claudio, et al.
Publicado: (2019)

Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
por: Mao, Yixiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j6v2u13l89qvkp82i4nknsnf0b